ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors
NCT02565758
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Undifferentiated Pleomorphic Sarcoma
Squamous Cell Carcinoma of the Head and Neck
Carcinoma of the Breast
Interventions
DRUG:
ABBV-085
Sponsor
AbbVie